JP2008522666A5 - - Google Patents

Download PDF

Info

Publication number
JP2008522666A5
JP2008522666A5 JP2007544609A JP2007544609A JP2008522666A5 JP 2008522666 A5 JP2008522666 A5 JP 2008522666A5 JP 2007544609 A JP2007544609 A JP 2007544609A JP 2007544609 A JP2007544609 A JP 2007544609A JP 2008522666 A5 JP2008522666 A5 JP 2008522666A5
Authority
JP
Japan
Prior art keywords
delivery system
contrast agent
composition
glutamic acid
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007544609A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008522666A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/044012 external-priority patent/WO2006060797A2/en
Publication of JP2008522666A publication Critical patent/JP2008522666A/ja
Publication of JP2008522666A5 publication Critical patent/JP2008522666A5/ja
Withdrawn legal-status Critical Current

Links

JP2007544609A 2004-12-03 2005-12-02 癌のためのｍｒｉガイド下光線力学的療法 Withdrawn JP2008522666A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63325504P 2004-12-03 2004-12-03
PCT/US2005/044012 WO2006060797A2 (en) 2004-12-03 2005-12-02 Mri guided photodynamic therapy for cancer

Publications (2)

Publication Number Publication Date
JP2008522666A JP2008522666A (ja) 2008-07-03
JP2008522666A5 true JP2008522666A5 (https=) 2009-01-29

Family

ID=36565853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007544609A Withdrawn JP2008522666A (ja) 2004-12-03 2005-12-02 癌のためのｍｒｉガイド下光線力学的療法

Country Status (9)

Country Link
US (1) US20090076571A1 (https=)
EP (1) EP1830879B1 (https=)
JP (1) JP2008522666A (https=)
KR (1) KR20070086803A (https=)
AT (1) ATE485836T1 (https=)
AU (1) AU2005311560A1 (https=)
CA (1) CA2589881A1 (https=)
DE (1) DE602005024437D1 (https=)
WO (1) WO2006060797A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2631704A1 (en) 2005-12-05 2007-06-14 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
US20080181852A1 (en) * 2007-01-29 2008-07-31 Nitto Denko Corporation Multi-functional Drug Carriers
CN101674852A (zh) * 2007-04-10 2010-03-17 日东电工株式会社 多功能聚谷氨酸盐药物载体
CN101707869A (zh) * 2007-05-09 2010-05-12 日东电工株式会社 具有多种药物的聚谷氨酸盐结合物和聚谷氨酸盐-氨基酸结合物
US20100284927A1 (en) * 2007-10-26 2010-11-11 University Of Utah Research Foundation Use of mri contrast agents for evaluating the treatment of tumors
CN102573910B (zh) * 2009-06-12 2015-08-26 鹿特丹伊拉斯谟大学医疗中心 用于癌症光动力学治疗的靶向纳米光药物
WO2013119957A1 (en) * 2012-02-10 2013-08-15 Aidan Research And Consulting, Llc Weight reduction through inactivation of gastric orexigenic mediator producing cells
TW201514188A (zh) * 2013-03-13 2015-04-16 Lantheus Medical Imaging Inc 製備釓磷維塞三鈉單水合物之方法
CN114870014B (zh) * 2022-05-18 2023-07-07 南京邮电大学 一种多功能抗肿瘤高分子药物及其制备方法和用途
US20250242170A1 (en) * 2024-01-25 2025-07-31 Todd Frank Ovokaitys Methods and Systems for Improving Photodynamic Therapy by Increasing Depth of Penetration Without Concurrently Increasing Energy Deposition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594136A (en) * 1989-12-21 1997-01-14 Pharmacyclics, Inc. Texaphyrin solid supports and devices
US6340461B1 (en) * 1996-12-17 2002-01-22 David Stephen Terman Superantigen based methods and compositions for treatment of diseases
DE19831217A1 (de) * 1998-07-03 2000-01-05 Schering Ag Neue Porphyrinderivate, diese enthaltende pharmazeutische Mittel und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik
US6534040B2 (en) * 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
WO2002087632A1 (en) * 2001-05-02 2002-11-07 Metaprobe, Inc. High throughput screening methods using magnetic resonance imaging agents

Similar Documents

Publication Publication Date Title
Meyers et al. Peptide‐targeted gold nanoparticles for photodynamic therapy of brain cancer
Lu et al. Hierarchical functional nanoparticles boost osteoarthritis therapy by utilizing joint-resident mesenchymal stem cells
Sharma et al. Gd nanoparticulates: from magnetic resonance imaging to neutron capture therapy
DK2125026T3 (en) FORMATIONS BASED ON bridged POLYCYCLIC COMPOUNDS FOR INHIBITION AND RELIEF OF DISEASES
JP2012513429A (ja) 浣腸製剤およびその使用
CN105491966B (zh) 用于去除尿道结石和/或尿道结石碎片的形成凝胶的体系
Vaidya et al. Contrast enhanced MRI‐guided photodynamic therapy for site‐specific cancer treatment
JP2010163445A (ja) 組織病変部の診断または治療のための溶液
JP2008522666A5 (https=)
JP2002512205A5 (https=)
CN111760036A (zh) 一种基于锰基的肿瘤诊疗一体化纳米材料、制备方法和应用
CN108904803A (zh) 聚乙烯亚胺修饰载光敏剂普鲁士蓝磁性纳米颗粒的制备
Liu et al. Three-arm polyrotaxanes with multidirectional molecular motions as the nanocarrier for nitric oxide-enhanced photodynamic therapy against bacterial biofilms in septic arthritis
CN113993554A (zh) 选自食道、咽喉、肺、脑和肠的癌症的靶向化合物
EP1830879B1 (en) Mri guided photodynamic therapy for cancer
WO2008074960A3 (fr) Nouveaux conjugues, utilisables a des fins therapeutiques, et/ou a titre d'agent de diagnostic et/ou d'imagerie et leur procede de preparation
TW200520777A (en) MRI contrast medium composition for oral administration
ES2312788T3 (es) Procedimiento de diagnostico fotodinamico para enfermedades vasculares.
JP2015500274A (ja) 化学的に修飾して上皮透過および細胞の生物学的利用能を増加させた光力学療法のための組成物
JP2002538201A (ja) 癌を診断および治療する手段
Zeng et al. NEWS & VIEWS NEWS & VIEWS NEWS & VIEWS
JP2000319197A (ja) 抗菌人体用男性女性ホルモン薬を用いての、人体のエイズ菌・癌菌，を抑止・死滅の効果、診断薬・治療薬。